Search

Your search keyword '"Bolcen, Shanna"' showing total 9 results
Start Over Author "Bolcen, Shanna" Publication Year Range Last 3 years
9 results on '"Bolcen, Shanna"'

1. Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccination

Author

Zhou, Zhao-Hua, Cortese, Margaret M., Fang, Jia-Long, Wood, Robert, Hummell, Donna S., Risma, Kimberly A., Norton, Allison E., KuKuruga, Mark, Kirshner, Susan, Rabin, Ronald L., Agarabi, Cyrus, Staat, Mary A., Halasa, Natasha, Ware, Russell E., Stahl, Anna, McMahon, Maureen, Browning, Peter, Maniatis, Panagiotis, Bolcen, Shanna, Edwards, Kathryn M., Su, John R., Dharmarajan, Sai, Forshee, Richard, Broder, Karen R., Anderson, Steven, and Kozlowski, Steven

Published
2023
Full Text
View/download PDF

2. Interlaboratory comparison of a multiplex immunoassay that measures human serum IgG antibodies against six-group B streptococcus polysaccharides

Author

Le Doare, Kirsty, primary, Gaylord, Michelle A., additional, Anderson, Annaliesa S., additional, Andrews, Nick, additional, Baker, Carol J., additional, Bolcen, Shanna, additional, Felek, Arif, additional, Giardina, Peter C., additional, Grube, Christopher D., additional, Hall, Tom, additional, Hallis, Bassam, additional, Izu, Alane, additional, Madhi, Shabir A., additional, Maniatis, Pete, additional, Matheson, Mary, additional, Mawas, Fatme, additional, McKeen, Andrew, additional, Rhodes, Julia, additional, Alston, Bailey, additional, Patel, Palak, additional, Schrag, Stephanie, additional, Simon, Raphael, additional, Tan, Charles Y., additional, Taylor, Stephen, additional, Kwatra, Gaurav, additional, and Gorringe, Andrew, additional

Published
2024
Full Text
View/download PDF

3. Examination of SARS-CoV-2 serological test results from multiple commercial and laboratory platforms with an in-house serum panel

Author

Lester, Sandra N., primary, Stumpf, Megan, additional, Freeman, Brandi D., additional, Mills, Lisa, additional, Schiffer, Jarad, additional, Semenova, Vera, additional, Jia, Tao, additional, Desai, Rita, additional, Browning, Peter, additional, Alston, Bailey, additional, Ategbole, Muyiwa, additional, Bolcen, Shanna, additional, Chen, Alexander, additional, David, Ebenezer, additional, Manitis, Panagiotis, additional, Tatum, Heather, additional, Qin, Yunlong, additional, Zellner, Briana, additional, Drobeniuc, Jan, additional, Tejada-Strop, Alexandra, additional, Chatterjee, Payel, additional, Shrivastava-Ranjan, Punya, additional, Jenks, M. Harley, additional, McMullan, Laura K., additional, Flint, Mike, additional, Spiropoulou, Christina F., additional, Niemeyer, Glenn P., additional, Werner, Bonnie J., additional, Bean, Christopher J., additional, Johnson, Jeffrey A., additional, Hoffmaster, Alex R., additional, Satheshkumar, Panayampalli S., additional, Schuh, Amy J., additional, Owen, S. Michele, additional, and Thornburg, Natalie J., additional

Published
2024
Full Text
View/download PDF

4. Development of A Standardized Opsonophagocytosis Killing Assay for Group B Streptococcus and Assessment in an Interlaboratory Study

Author

Leung, Stephanie, primary, Collett, Clare F., additional, Allen, Lauren, additional, Lim, Suzanna, additional, Maniatis, Pete, additional, Bolcen, Shanna J., additional, Alston, Bailey, additional, Patel, Palak Y., additional, Kwatra, Gaurav, additional, Hall, Tom, additional, Thomas, Stephen, additional, Taylor, Stephen, additional, Le Doare, Kirsty, additional, and Gorringe, Andrew, additional

Published
2023
Full Text
View/download PDF

5. Examination of SARS-CoV-2 serological test results from multiple commercial and laboratory platforms with an in-house serum panel

Author

Lester, Sandra N., primary, Stumpf, Megan, additional, Freeman, Brandi D., additional, Mills, Lisa, additional, Schiffer, Jarad, additional, Semenova, Vera, additional, Jia, Tao, additional, Desai, Rita, additional, Browning, Peter, additional, Alston, Bailey, additional, Ategbole, Muyiwa, additional, Bolcen, Shanna, additional, Chen, Alexander, additional, David, Ebenezer, additional, Manitis, Panagiotis, additional, Tatum, Heather, additional, Qin, Yunlong, additional, Zellner, Briana, additional, Drobeniuc, Jan, additional, Tejada-Strop, Alexandra, additional, Chatterjee, Payel, additional, Shrivastava-Ranjan, Punya, additional, Jenks, M. Harley, additional, McMullan, Laura K., additional, Flint, Mike, additional, Spiropoulou, Christina F., additional, Niemeyer, Glenn P., additional, Werner, Bonnie J., additional, Bean, Christopher J., additional, Johnson, Jeffrey A., additional, Hoffmaster, Alex R., additional, Satheshkumar, Panayampalli S., additional, Schuh, Amy J., additional, Owen, S. Michele, additional, and Thornburg, Natalie J., additional

Published
2023
Full Text
View/download PDF

6. Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccination

Author

Zhou, Zhao-Hua, primary, Cortese, Margaret M., additional, Fang, Jia-Long, additional, Wood, Robert, additional, Hummell, Donna S., additional, Risma, Kimberly A., additional, Norton, Allison E., additional, KuKuruga, Mark, additional, Kirshner, Susan, additional, Rabin, Ronald L., additional, Agarabi, Cyrus, additional, Staat, Mary A., additional, Halasa, Natasha, additional, Ware, Russell, additional, Stahl, Anna, additional, McMahon, Maureen, additional, Browning, Peter, additional, Maniatis, Panagiotis, additional, Bolcen, Shanna, additional, Edwards, Kathryn M., additional, Su, John R., additional, Dharmarajan, Sai, additional, Forshee, Richard, additional, Broder, Karen R., additional, Anderson, Steven, additional, and Kozlowski, Steven, additional

Published
2023
Full Text
View/download PDF

7. Household Transmission and Symptomology of Severe Acute Respiratory Syndrome Coronavirus 2 Alpha Variant among Children—California and Colorado, 2021

Author

Waltenburg, Michelle A., primary, Whaley, Melissa J., additional, Chancey, Rebecca J., additional, Donnelly, Marisa A.P., additional, Chuey, Meagan R., additional, Soto, Raymond, additional, Schwartz, Noah G., additional, Chu, Victoria T., additional, Sleweon, Sadia, additional, McCormick, David W., additional, Uehara, Anna, additional, Retchless, Adam C., additional, Tong, Suxiang, additional, Folster, Jennifer M., additional, Petway, Marla, additional, Thornburg, Natalie J., additional, Drobeniuc, Jan, additional, Austin, Brett, additional, Hudziec, Meghan M., additional, Stringer, Ginger, additional, Albanese, Bernadette A., additional, Totten, Sarah E., additional, Matzinger, Shannon R., additional, Staples, J. Erin, additional, Killerby, Marie E., additional, Hughes, Laura J., additional, Matanock, Almea, additional, Beatty, Mark, additional, Tate, Jacqueline E., additional, Kirking, Hannah L., additional, Hsu, Christopher H., additional, Alford, Alexis, additional, Baird, Samuel, additional, Bankers, Laura, additional, Bello, Jazmin, additional, Bolcen, Shanna, additional, Browning, Peter, additional, Cook, Peter W., additional, David, Ebenezer, additional, Harcourt, Jennifer L., additional, Hareland, Geir, additional, Hetherington-Rauth, Molly C., additional, Ir, Diana, additional, Jain, Shilpi, additional, Jia, Tao Lily, additional, Johnson, Ralen, additional, Kelleher, Anna, additional, Kim, Gimin, additional, Li, Yan, additional, Lynch, Brian, additional, Mallal, Daniel, additional, Maniatis, Panagiotis, additional, Marine, Rachel, additional, Medrzycki, Magdalena, additional, Metz, John M., additional, Montmayeur, Anna Maria, additional, Moss, Kimberly M., additional, Justin Ng, Han Jia, additional, Nyugen, Van, additional, Ortiz, Kristina, additional, Paden, Clinton R., additional, Park, So Hee, additional, Queen, Krista, additional, Rossheim, Alexandria E.B., additional, Semenova, Vera, additional, Shepard, Samuel S., additional, Tamin, Azaibi, additional, Tao, Ying, additional, Tejada-Strop, Alexandra, additional, Wong, Phili, additional, Zellner, Briana, additional, and Zhang, Jing, additional

Published
2022
Full Text
View/download PDF

8. Examination of SARS-CoV-2 serological test results from multiple commercial and laboratory platforms with an in-house serum panel

Author

Lester, Sandra N., primary, Stumpf, Megan, additional, Freeman, Brandi D., additional, Mills, Lisa, additional, Schiffer, Jarad, additional, Semenova, Vera, additional, Jia, Tao, additional, Desai, Rita, additional, Browning, Peter, additional, Alston, Bailey, additional, Ategbole, Muyiwa, additional, Bolcen, Shanna, additional, Chen, Alexander, additional, David, Ebenezer, additional, Manitis, Panagiotis, additional, Tatum, Heather, additional, Qin, Yunlong, additional, Zellner, Briana, additional, Drobeniuc, Jan, additional, Tejada-Strop, Alexandra, additional, Chatterjee, Payel, additional, Shrivastava-Ranjan, Punya, additional, Jenks, M. Harley, additional, McMullan, Laura K., additional, Flint, Mike, additional, Spiropoulou, Christina F., additional, Niemeyer, Glenn P., additional, Werner, Bonnie J., additional, Bean, Christopher J., additional, Johnson, Jeffrey A., additional, Hoffmaster, Alex R., additional, Satheshkumar, Panayampalli S., additional, Schuh, Amy J., additional, Owen, S. Michele, additional, and Thornburg, Natalie J., additional

Published
2022
Full Text
View/download PDF

9. Examination of SARS-CoV-2 serological test results from multiple commercial and laboratory platforms with an in-house serum panel.

Author

Lester SN, Stumpf M, Freeman BD, Mills L, Schiffer J, Semenova V, Jia T, Desai R, Browning P, Alston B, Ategbole M, Bolcen S, Chen A, David E, Manitis P, Tatum H, Qin Y, Zellner B, Drobeniuc J, Tejada-Strop A, Chatterjee P, Shrivastava-Ranjan P, Jenks MH, McMullan LK, Flint M, Spiropoulou CF, Niemeyer GP, Werner BJ, Bean CJ, Johnson JA, Hoffmaster AR, Satheshkumar PS, Schuh AJ, Owen SM, and Thornburg NJ

Abstract

Severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) is a novel human coronavirus that was identified in 2019. SARS-CoV-2 infection results in an acute, severe respiratory disease called coronavirus disease 2019 (COVID-19). The emergence and rapid spread of SARS-CoV-2 has led to a global public health crisis, which continues to affect populations across the globe. Real time reverse transcription polymerase chain reaction (rRT-PCR) is the reference standard test for COVID-19 diagnosis. Serological tests are valuable tools for serosurveillance programs and establishing correlates of protection from disease. This study evaluated the performance of one in-house enzyme linked immunosorbent assay (ELISA) utilizing the pre-fusion stabilized ectodomain of SARS-CoV-2 spike (S), two commercially available chemiluminescence assays Ortho VITROS Immunodiagnostic Products Anti-SARS-CoV-2 Total Reagent Pack and Abbott SARS-CoV-2 IgG assay and one commercially available Surrogate Virus Neutralization Test (sVNT), GenScript USA Inc., cPass SARS-CoV-2 Neutralization Antibody Detection Kit for the detection of SARS-CoV-2 specific antibodies. Using a panel of rRT-PCR confirmed COVID-19 patients' sera and a negative control group as a reference standard, all three immunoassays demonstrated high comparable positivity rates and low discordant rates. All three immunoassays were highly sensitive with estimated sensitivities ranging from 95.4-96.6 %. ROC curve analysis indicated that all three immunoassays had high diagnostic accuracies with area under the curve (AUC) values ranging from 0.9698 to 0.9807. High positive correlation was demonstrated among the conventional microneutralization test (MNT) titers and the sVNT inhibition percent values. Our study indicates that independent evaluations are necessary to optimize the overall utility and the interpretation of the results of serological tests. Overall, we demonstrate that all serological tests evaluated in this study are suitable for the detection of SARS-CoV-2 antibodies., Competing Interests: ‘The author(s) declare that there are no conflicts of interest’. The findings and conclusions in this report are those of the author(s) and do not necessarily represent the official position of the Centers for Disease Control and Prevention. Names of specific vendors, manufacturers, or products are included for public health and informational purposes; inclusion does not imply endorsement of the vendors, manufacturers, or products by the Centers for Disease Control and Prevention or the US Department of Health and Human Services.

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results